Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
In March, manufacturing PMI returned to the expansion zone. Focus on A500 ETF E Fund (159361) and ChiNext ETF E Fund (159915) investment value
The latest data from the National Bureau of Statistics shows that in March, the level of manufacturing business confidence increased. Market demand was released more strongly, and overall corporate production activities rebounded. China’s Manufacturing Purchasing Managers’ Index (PMI) was 50.4%, up 1.4 percentage points from the previous month, returning to the expansion zone. In terms of structure, the high-tech manufacturing PMI was 52.1%, up 0.6 percentage points from the previous month. It has been above the critical point for 14 consecutive months, indicating that the development trend in industries related to new quality productive forces continues to improve.
The A500 ETF from E Fund (159361; feeder fund A/C/Y: 022459/022460/022930) tracks the CSI A500 Index, which focuses on large-cap companies with better liquidity. Its industry distribution is well-balanced, and it has a high share of new quality productive forces. The ChiNext ETF from E Fund (159915; feeder fund A/C/Y: 110026/004744/022907) tracks the ChiNext Index, which consists of 100 large- and liquid-cap stocks from the ChiNext market. It focuses on high-growth sectors such as communications, electrical equipment, and biopharmaceuticals.
The scale of both products ranks among the top in ETFs tracking the same underlying index. They have good liquidity and a management fee rate of only 0.15% per year, which can help investors take a low-cost approach to investing along the main lines of economic recovery and industrial upgrading.
Daily Economic News